Ray Asghari

Bankstown, NSW, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Time toxicity associated with treatment of metastatic or unresectable gastro-oesophageal cancers in the second-line setting.

Time toxicity associated with treatment of metastatic or unresectable gastro-oesophageal cancers in the second-line setting.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: June 27, 2025

RAS-variant allele frequency as a potential prognostic marker of overall survival in patients with metastatic colorectal cancer.

RAS-variant allele frequency as a potential prognostic marker of overall survival in patients with metastatic colorectal cancer.

Journal: Cancer treatment and research communications

Published: September 18, 2024

Adherence Outcomes and Risk Factors Predicting Nonadherence to Active Surveillance in Patients With Stage 1 Testicular Germ Cell Tumors.

Adherence Outcomes and Risk Factors Predicting Nonadherence to Active Surveillance in Patients With Stage 1 Testicular Germ Cell Tumors.

Journal: Clinical genitourinary cancer

Published: March 19, 2024

Circulating Tumour Cell Associated MicroRNA Profiles Change during Chemoradiation and Are Predictive of Response in Locally Advanced Rectal Cancer.

Circulating Tumour Cell Associated MicroRNA Profiles Change during Chemoradiation and Are Predictive of Response in Locally Advanced Rectal Cancer.

Journal: Cancers

Published: June 22, 2023

Multigene panel next generation sequencing in metastatic colorectal cancer in an Australian population.

Multigene panel next generation sequencing in metastatic colorectal cancer in an Australian population.

Journal: PloS one

Published: May 21, 2023

Clinical Response to Seribantumab, an Anti-Human Epidermal Growth Factor Receptor-3 Immunoglobulin 2 Monoclonal Antibody, in a Patient With Metastatic Pancreatic Ductal Adenocarcinoma Harboring an NRG1 Fusion.

Clinical Response to Seribantumab, an Anti-Human Epidermal Growth Factor Receptor-3 Immunoglobulin 2 Monoclonal Antibody, in a Patient With Metastatic Pancreatic Ductal Adenocarcinoma Harboring an NRG1 Fusion.

Journal: JCO precision oncology

Published: December 01, 2022

Haematological and nutritional prognostic biomarkers for patients receiving CROSS or FLOT.

Haematological and nutritional prognostic biomarkers for patients receiving CROSS or FLOT.

Journal: Journal of gastrointestinal oncology

Published: September 12, 2022

Real-World Outcomes of FLOT versus CROSS Regimens for Patients with Oesophagogastric Cancers.

Real-World Outcomes of FLOT versus CROSS Regimens for Patients with Oesophagogastric Cancers.

Journal: Gastrointestinal tumors

Published: August 25, 2022

Real-world tolerance and outcomes of oxaliplatin-based adjuvant chemotherapy for stage III colon cancer-Does dose intensity matter?

Real-world tolerance and outcomes of oxaliplatin-based adjuvant chemotherapy for stage III colon cancer-Does dose intensity matter?

Journal: Asia-Pacific journal of clinical oncology

Published: June 15, 2022

Health-Related Quality of Life during Chemoradiation in Locally Advanced Rectal Cancer: Impacts and Ethnic Disparities.

Health-Related Quality of Life during Chemoradiation in Locally Advanced Rectal Cancer: Impacts and Ethnic Disparities.

Journal: Cancers

Published: July 25, 2019

Decline in Left Ventricular Ejection Fraction Following Anthracyclines Predicts Trastuzumab Cardiotoxicity.

Decline in Left Ventricular Ejection Fraction Following Anthracyclines Predicts Trastuzumab Cardiotoxicity.

Journal: JACC. Heart failure

Published: December 19, 2018

An unusual presentation: breast metastases imitating a gastric primary - first Australian case reported.

An unusual presentation: breast metastases imitating a gastric primary - first Australian case reported.

Journal: Internal medicine journal

Published: September 13, 2017

Showing 1-12 of 17

Last Updated: 09/26/2026